Skip to main content
S 2150 113th Congress Senate

Independent Innovator and Repurposing Act

Official title: A bill to advance the public health by encouraging independent innovators to pursue drug repurposing research and develop new treatments and cures by providing… Show full official titleShow less

Official title: A bill to advance the public health by encouraging independent innovators to pursue drug repurposing research and develop new treatments and cures by providing appropriate intellectual property protections for those innovations, and for other purposes.

Introduced: March 24, 2014 Introduced by: Blumenthal, Richard Democratic · Connecticut See on congress.gov
Commerce Health technology, devices, suppliesIntellectual propertySmall business
Sign in to write a letter Sign in to watch
This bill died when the 113th Congress ended
It never became law before the 113th Congress (2013–2014) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 24, 2014
Read twice and referred to the Committee on the Judiciary.
Mar 24, 2014
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action March 24, 2014

Read twice and referred to the Committee on the Judiciary.

 Plain-English summary Congressional Research Service

Independent Innovator and Repurposing Act - Establishes procedures under which the term of an unexpired patent claiming a method of using a biological product shall be extended for five years from its original expiration date.

Requires an application for such an extension to demonstrate that: (1) the patent was issued to an independent innovator, and (2) the owner of record is the independent innovator or a small business (with fewer than 500 employees and which is not affiliated with the holder of the marketing application approved under licensing requirements of the Public Health Service Act for the commercial marketing of such biological product) in which the independent innovator has an ownership interest.

Defines "independent innovator" as a person or entity that obtains a method of use patent for a biological product and is not, at the time of invention or patent filing, affiliated with the holder of an approved application for the commercial marketing of the product.

 Related & companion bills 1
  • HR 4287 Identical bill Independent Innovator and Repurposing Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2150: Independent Innovator and Repurposing Act. 113th Congress. Open America. https://openamerica.io/bill/113-S-2150/
MLA
"S. 2150: Independent Innovator and Repurposing Act." 113th Congress, 2026, Open America, https://openamerica.io/bill/113-S-2150/.
Bluebook (legal)
S. 2150, 113th Cong. (2026), https://openamerica.io/bill/113-S-2150/.
Markdown link
[S. 2150: Independent Innovator and Repurposing Act](https://openamerica.io/bill/113-S-2150/)
Report a problem